A week after the U.S. Food and Drug Administration (FDA) warned about cybersecurity risks attached to some models of insulin pumps manufactured by American medical equipment supplier Medtronic, India’s apex drug regulator, the Central Drug Standard Control Organisation (CDSCO) has also issued an alert. CDSCO noted that some models were vulnerable to hackers and an unauthorised person with technical skills and equipment could potentially connect wirelessly to a nearby insulin pump to change the settings and control insulin delivery. It further advises patients to disconnect the USB device from their computer when it is not being used to download data from their pump. The affected models include Minimed Paradigm (MMT-715, MMT-712 & MMT-722) and MiniMed Paradigm Veo (MMT-754) Insulin Pump. Medtronic provided its customers and their doctors with recommended security precautions when using their insulin pump.

Source: The Hindu July 04, 2019 09:22 UTC